Phosphoproteins involved in the mode of action of antidepressants and electroconvulsive shock: a possible role of cytoskeletal proteins.
Miyamoto
S
S
Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki.
Nakanishi
J
J
Asakura
M
M
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D015153:Blotting, Western; D002540:Cerebral Cortex / Q000187:drug effects* / Q000502:physiology; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D004565:Electroconvulsive Therapy; D006624:Hippocampus / Q000187:drug effects* / Q000502:physiology; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D010750:Phosphoproteins / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology
D000928:Antidepressive Agents; D003598:Cytoskeletal Proteins; D010750:Phosphoproteins; D007099:Imipramine